HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoki Yamamoto Selected Research

KRH 1636

4/2009Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists.
4/2003A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoki Yamamoto Research Topics

Disease

82Infections
01/2022 - 03/2002
77Neoplasms (Cancer)
11/2022 - 02/2002
22Alzheimer Disease (Alzheimer's Disease)
05/2021 - 06/2003
19Liver Cirrhosis (Hepatic Cirrhosis)
11/2020 - 10/2003
18Virus Diseases (Viral Diseases)
03/2020 - 12/2004
15Neoplasm Metastasis (Metastasis)
11/2020 - 02/2002
14Fibrosis (Cirrhosis)
11/2020 - 12/2007
11Schizophrenia (Dementia Praecox)
01/2022 - 12/2007
11Cataract (Cataracts)
12/2021 - 03/2003
11Inflammation (Inflammations)
09/2021 - 05/2004
11Hepatocellular Carcinoma (Hepatoma)
01/2020 - 05/2003
11Acquired Immunodeficiency Syndrome (AIDS)
02/2013 - 12/2004
11Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2012 - 02/2002
10Pancreatic Neoplasms (Pancreatic Cancer)
07/2020 - 03/2008
9HIV Infections (HIV Infection)
01/2015 - 04/2004
9T-Cell Leukemia (Leukemia, T Cell)
04/2009 - 02/2002
8Hypoxia (Hypoxemia)
05/2020 - 02/2010
8Pathologic Constriction (Stenosis)
01/2020 - 05/2013
8Rheumatoid Arthritis
01/2019 - 07/2004
7Human Influenza (Influenza)
11/2021 - 06/2011
6Hypertension (High Blood Pressure)
05/2021 - 04/2006
6Psychotic Disorders (Schizoaffective Disorder)
12/2020 - 09/2004
6Liver Diseases (Liver Disease)
05/2020 - 11/2002
5Wounds and Injuries (Trauma)
10/2022 - 03/2007
5Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 06/2016
5Fatty Liver
09/2021 - 07/2010
5Carcinoma (Carcinomatosis)
11/2020 - 02/2010
5Breast Neoplasms (Breast Cancer)
01/2014 - 08/2003
4Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 02/2016
4Amyloidosis
06/2022 - 01/2019
4Mental Disorders (Mental Disorder)
11/2020 - 01/2003
4Influenza in Birds (Avian Flu)
10/2020 - 07/2012
4Hepatitis B
11/2019 - 07/2004
4Vesicular Stomatitis
03/2015 - 04/2001
4Pheochromocytoma
10/2011 - 05/2007
3Colitis
06/2022 - 11/2008
3Communicable Diseases (Infectious Diseases)
05/2022 - 01/2016
3COVID-19
01/2022 - 10/2020

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2003
22VaccinesIBA
01/2022 - 12/2002
17Pharmaceutical PreparationsIBA
01/2022 - 04/2002
14Amyloid (Amyloid Fibrils)IBA
06/2022 - 04/2008
13DNA (Deoxyribonucleic Acid)IBA
11/2022 - 03/2004
13Antiviral Agents (Antivirals)IBA
11/2021 - 03/2004
13AntigensIBA
03/2021 - 03/2004
12NF-kappa B (NF-kB)IBA
02/2009 - 09/2002
11Messenger RNA (mRNA)IBA
11/2020 - 12/2003
10CytokinesIBA
01/2022 - 08/2006
10Peptides (Polypeptides)IBA
11/2021 - 03/2002
10Carbon Tetrachloride (Tetrachloromethane)IBA
11/2020 - 10/2003
10Chemokine ReceptorsIBA
01/2019 - 03/2002
10Amyloid beta-PeptidesIBA
06/2010 - 05/2004
9Amino AcidsFDA Link
11/2020 - 07/2004
9Small Interfering RNA (siRNA)IBA
11/2017 - 12/2004
8IronIBA
05/2022 - 05/2014
8N-Methylaspartate (NMDA)IBA
01/2022 - 07/2007
8Therapeutic UsesIBA
01/2022 - 11/2011
8EnzymesIBA
01/2022 - 04/2002
8Biological ProductsIBA
12/2021 - 01/2006
7Chelating AgentsIBA
05/2022 - 05/2014
7Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2021 - 04/2006
7AntibodiesIBA
11/2016 - 05/2006
7LigandsIBA
04/2011 - 03/2003
6MicroRNAs (MicroRNA)IBA
05/2020 - 01/2014
6Polysaccharides (Glycans)IBA
01/2016 - 11/2007
6Phosphotransferases (Kinase)IBA
01/2012 - 02/2005
5Insulin (Novolin)FDA Link
09/2022 - 05/2010
5Deferoxamine (Desferal)FDA LinkGeneric
05/2022 - 05/2014
5Hemagglutinins (Hemagglutinin)IBA
11/2021 - 05/2007
5Choline (Choline Chloride)IBA
11/2020 - 12/2007
5Indicators and Reagents (Reagents)IBA
05/2020 - 03/2009
5InterferonsIBA
01/2019 - 09/2015
5Viral DNAIBA
03/2017 - 10/2003
5G(M1) GangliosideIBA
05/2012 - 12/2006
5T140 peptideIBA
06/2006 - 03/2002
4Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 04/2012
4Glutamate Receptors (Glutamate Receptor)IBA
01/2022 - 06/2015
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 03/2003
4GTP-Binding Proteins (G-Protein)IBA
05/2021 - 04/2001
4Antipsychotic Agents (Antipsychotics)IBA
12/2020 - 07/2007
4Tumor Biomarkers (Tumor Markers)IBA
11/2020 - 07/2004
4CDAA (Randox)IBA
11/2020 - 12/2007
4DeferasiroxFDA Link
07/2020 - 01/2016
4AcidsIBA
01/2020 - 05/2002
4InterleukinsIBA
01/2019 - 10/2006
4GemcitabineFDA Link
06/2018 - 03/2008
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018 - 07/2007
4Glycoproteins (Glycoprotein)IBA
05/2015 - 04/2001
4Aquaporins (Water Channels)IBA
01/2015 - 12/2003
4Complementary DNA (cDNA)IBA
04/2011 - 01/2006
4Neutralizing AntibodiesIBA
07/2008 - 08/2003
4I-kappa B KinaseIBA
03/2008 - 05/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 06/2006
3Immunoglobulin G (IgG)IBA
01/2022 - 01/2016

Therapy/Procedure

47Therapeutics
05/2022 - 08/2003
19Drug Therapy (Chemotherapy)
02/2022 - 09/2003
9Stents
11/2018 - 10/2008
8Transplantation
06/2020 - 10/2003
4Lenses
11/2021 - 01/2012
4Immunotherapy
06/2020 - 06/2006